Biotech Investors & VC Firms in Middle East & North Africa
209 firms in this list, with a median first check of $500K. 53 of them lead rounds. Generated from verified public data and updated continuously.
MCI Capital S.A.
WarsawGrowth–Late Stage$27M – $108M
2 people
Asbis
Limassol
Robust
San FranciscoPre-Seed–Series B$1M – $2M
1 person
Ferocity Capital
Palo Alto
3 people
AngelMD
DenverSeed–Series A
2 people
Ela Capital
TorontoPre-Seed–Growth
3 people
Aescuvest
Frankfurt am MainSeed–Series B
1 person
Global Startup Acceleration Program (JETRO GSAP)
TokyoPre-Seed–Late Stage
Next Sequence
2 people
Virtus Inspire Ventures
Seed–Series A
7 people
Stonebridge Ventures
SeoulSeries A–Series C
3 people
Mankind Pharma
New DelhiSeries A
eureKARE
Seed
Be8 Ventures
BerlinSeed–Series A$2.2M – $10.8M
2 people
Esperante Ventures
LondonSeed–Series A$540K – $5.4M
1 person
HSBC Innovation Ventures
LondonSeed–Growth
1 person
Fubon Financial Holdings
TaipeiSeries A–Series B
Related lists
Investors & VC Firms in North America (12910)Investors & VC Firms in United States (11953)Investors & VC Firms in Europe (5849)Investors & VC Firms in Global (4765)AI & Machine Learning Investors & VC Firms (4583)Fintech Investors & VC Firms (4561)SaaS Investors & VC Firms (4227)Healthtech Investors & VC Firms (4206)Enterprise Software Investors & VC Firms (4109)Crypto & Web3 Investors & VC Firms (3976)
Data sourced from public filings and firms' own websites — see our methodology.
















